Woven Data, Inc. was founded in 2017, bringing together experts in the Pharma, Business Intelligence, and Technology fields.

We provide contract and pricing managed services, analytics, and advisory support to pharmaceutical manufacturers, delivered via a fully integrated cloud-based data and analytics platform. We are privately held, and focused on the single goal of empowering clients to derive insights, make data-driven decisions, and maximize the value of their portfolio and commercial strategies throughout all phases of their product lifecycle.

Executive Team

Jeff Crawford

Linkedin
Head of sales and business development

Jeff leads Sales and Business Development at Woven Data. He has deep experience partnering with Life Sciences companies to help them solve data science, revenue management, and compliance challenges, including work at Certara, Model N, and Revitas/iMANY. Jeff earned his BS in Chemical Engineering from Pennsylvania State University and an MBA in Finance from Temple University.

Scott Hoffman

Linkedin
Head of Client services

Scott leads Client Services at Woven Data. His expertise is in Pharma Market Access and Government Programs. Before co-founding Woven Data, Scott was the VP of Market Access and Commercial Operations at Covis Pharma, and prior to there he worked with numerous manufacturers at CIS and Alliance Life Sciences. Scott earned his BS in Accounting from Pennsylvania State University.

Sergei Krupenin

Linkedin
Chief executive officer

Sergei leads Product Development and is the CEO of Woven Data. Prior to co-founding the company, he was building products at Twitter, and held Product, Marketing, and Engineering roles at a number of tech startups. Sergei earned his Masters Degrees in Management and Engineering from Stanford, and a BS from MIT.

Board of Advisors

Mary Bordeaux

Linkedin

Mary is an independent consultant focusing on commercialization strategies for emerging companies and therapies, with projects spanning the development, acquisition, and commercialization phases of pharma companies. Clients rely on Mary's expertise to establish and test a product's value proposition and pricing sensitivity, identify barriers to product access, and develop a roadmap for market access — including payer coverage and reimbursement, channel access, coding and policy changes, as well as applying for and obtaining billing codes. Mary has over 30 years in the pharmaceutical industry.

Dave Janca

Linkedin

Dave founded and built ValueCentric into the leading provider of channel data management, analytics, and reporting solutions for pharma. Its ValueTrak platform is used by pharmaceutical manufacturers, wholesalers, and retailers. Dave’s vision for data access, channel monitoring, and real-time reporting helped pioneer channel data analytics in the industry. ValueCentric was acquired by IQVIA (NYSE: IQV) in 2019. Previously, Dave co-founded Supply Chain Solutions, now part of Manhattan Associates (NASDAQ: MANH). He is deeply involved in his community and not-for-profit organizations, including The Janca Family Foundation, which he started in 2019, and he also runs Aviano Ventures, a private investment company and family office.

Lynne Marton

Linkedin

Lynne is highly respected for her deep expertise in government contracting, pricing, and compliance. Prior to retiring from consulting, she ran her own successful consulting practice for over 20 years, and helped more than 60 emerging and established pharmaceutical companies comply with federally mandated contract and price reporting requirements. She started her career at Syntex Corporation and Roche.

Andrei Kolodovski

Linkedin

Prior to starting the company, he spent more than a few years wrestling data for Fortune 500 companies, by building Data Warehousing and Data Science solutions. Andrei holds an MBA from Stanford, and an MS from the Belarusian State University.

Talk to an Expert

Get Started